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ABSTRACT
Bustamante, David J M.S.B.M.E., Purdue University, May 2020. Analysis of Heart
Rate Variability During Focal Parasympathetic Drive of the Rat Baroreflex. Major
Professor: John Schild.
Autonomic control of the heart results in variations in the intervals between heart
beats, known as heart rate variability. One of the defining components of autonomic
control is the baroreflex, a negative feedback controller that balances heart rate and
blood pressure. The baroreflex is under constant command from the branches of the
autonomic nervous system. To better understand how the autonomic nervous system
commands the baroreflex, a baroreflex reflexogenic animal protocol was carried out.
Heart rate variability analysis and baroreflex sensitivity were used to quantify the
neural control of the heart. This thesis reconfirmed the existence of sexually dimor-
phic properties in the baroreflex through the use of heart rate variability analysis
and baroreflex sensitivity. It was discovered that there are many caveats to utilizing
heart rate variability analysis, which have to be addressed both in the experimental
protocol and the signal processing technique. Furthermore, it was suggested that the
slope method for quantifying baroreflex sensitivity also has many caveats, and that
other baroreflex sensitivity methods are likely more optimal for quantifying sustained
activation of the baroreflex. By utilizing various heart rate variability signal pro-
cessing algorithms to assess autonomic tone in Sprague-Dawley rats during rest and
sustained electrical activation of the baroreflex, the null hypothesis was rejected.
1
CHAPTER 1. INTRODUCTION
1.1 Quantitative Assessment of Autonomic Tone in Cardiovascular Home-
ostasis
1.1.1 Background and Historical Significance
Since 1921, cardiovascular disease (CVD) has been the leading cause of death
in the United States [1]. In 2017, CVD was cited as the cause of death of about
650,000 people in the US, and about 18,000,000 worldwide [2]. Since 1950, CVD
has decreased by about 60 percent in the United States, but still accounts for a
fourth of all annual deaths in the US, surpassing cancer and all other diseases. The
decrease has been largely the result of advances in clinical understanding of cardio-
vascular health and disease along with advances in technology, clinical intervention
techniques, pharmaceuticals, and lifestyle changes that promote a more healthy car-
diovascular physiology [1]. Nonetheless, the worldwide prevalence of CVD continues
to increase. The most common risk factors include an unhealthy diet, lack of physical
activity, consumption of alcohol, and tobacco use [1]. Several risks are hereditary.
The CDC reports CVD prevalence is higher in men than women [1]. Whites and
African Americans have the highest prevalence of CVD in the US [1]. Prevalence of
CVD in people above 50 years old is more than an order of magnitude higher than
those below 25 [1].
Two of the most commonly utilized methods for assessing cardiovascular health
are measures of blood pressure (BP) and heart rate (HR). These measurements are
taken in clinics because they are procedurally simple, inexpensive, and noninvasive.
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They have high correlation to the overall function of the cardiovascular system (CVS)
and a high BP or abnormal HR are two of the highest risk factors for CVD [2,3].
There is an on-going demand for easily implementable and non-invasive diagnostic
measures like BP and HR in modern medicine. In the last fifty years, more method-
ologies have evolved, often involving sophisticated signal processing techniques. These
utilize complex algorithms to extract useful information about the health of a patient
while remaining non-invasive and simple to implement, making them useful in clinical
practice. These methodologies rely on the data collected from common clinical tests
such as drug infusion (e.g. nitroglycerin or phenylephrine) or mechanical tests (e.g.
tilt table or treadmill).
1.1.2 Anatomy, Physiology, and Neural Control of the Heart
The heart is a muscular organ that drives blood flow by contracting to push the
blood through its four chambers, termed the atria and ventricles (figure 1.1). This is
a repetitive cycle that allows the blood to be oxygenated in the lungs, distributed to
peripheral and central arterial circulation, and returned to the right atrium via the
venous network where the deoxygenated blood is returned to the lungs [4]. The timing
and intensity of the contractions of the heart are under both neuronal and hormonal
control. These control pathways work together to ensure that cardiac output meets
physiological demand.
The body is constantly driven to maintain a sufficient level of cardiac output, an
effort known as cardiovascular homeostasis. This effort largely manifests as blood
being transported and directed per the metabolic and hemodynamic demands needed
by each organ system. This balance is maintained by neural and hormonal mecha-
nisms that are predominately associated with the autonomic nervous system (ANS)
acting by sympathetic and parasympathetic pathways. This is accomplished through
the action of a highly integrated network of sensory feedback pathways and central
neural circuitry of the ANS.
3
Fig. 1.1 Diagram of the heart [4]. Deoxygenated blood (blue) travels through the
right side of the heart before being reoxygenated (red) in the lungs. It then travels
through the left side of the heart and into the rest of the body.
1.1.3 Rhythmic Control of the Heart
There is an active coordination between respiration and HR that is termed respi-
ratory sinus arrhythmia (RSA) [5–7]. During inspiration, HR increases while during
expiration, HR decreases, resulting in a cyclical HR. This phenomenon is controlled
by the brain primarily through the vagal nerve, with minimal sympathetic nervous
system influence [5]. RSA is beneficial for perfusion of oxygen in the lungs and energy
conservation [5,6]. By modulating the timing of the HR, it allows for a more efficient
absorption of oxygen into the blood.
There is also a coordination between BP and HR termed the baroreceptor reflex
(BRx). The BRx is mediated by stress-sensing nerve endings called baroreceptors.
Baroreceptors are mechanical receptors that detect changes in BP and communicate
those changes to the central nervous system (CNS) [8]. Any neural activity encoded
in the peripherals and sent as an input to the CNS is termed afferent communication.
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The CNS responds appropriately to BP changes by sending information to alter HR
as necessary. This output to the peripherals is termed efferent communication.
All neural and hormonal control mechanisms such as RSA and the BRx each
have a designated structure of afferent and efferent fibers, forming a sophisticated
neuroanatomical structure. When one controller generates a perturbation, it has
rippling effects. There is a ceaseless exchange of information, creating a constant
oscillation around cardiovascular homeostasis.
1.1.4 Clinical Assessment of Cardiovascular Homeostasis
Electrocardiography is the study of the electrical propagation of activity in the
heart. This is most often accomplished by measuring the faint voltage fields generated
at the body surface from the electrical activity of the heart by using patch electrodes,
termed a surface electrocardiogram (ECG). Such signals can provide critically impor-
tant information about the electrical and mechanical state of the heart. The heart’s
electrical pathway is defined by spatial and temporal components that integrate to
form the commonly seen P-QRS-T complex (figure 1.2).
An ECG provides information about the rate, rhythmicity, depolarization, con-
duction, and contraction of the heart. HR is often obtained by measuring the time
series of the distinct R waves, which each indicate the contraction of the ventricles
in the heart. Heart rhythm refers to the proper timing and coordination of the
heartbeats in sequence. When heart rhythm is off, the beating can be slow, fast, or
irregular. Depolarization (ion exchange) of the pacemaker cells in the heart create
impulses to drive the sequential electrical pathway. Problems with depolarization
can cause irregularities in the heart rhythm. Conduction is the ability of the heart
cells to sequentially depolarize, allowing the formation of a continuous chronological
pathway. Problems with conduction can severely hinder the heart’s electrical function
and thus are involved in most arrhythmias. Contraction is the result of the electrical
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Fig. 1.2 Netter’s diagram of human ECG [9]. The combined and sequential efforts of
the electrophysiological anatomy create an overall ECG (seen at bottom right).
impulses driving muscle fibers in each chamber of the heart. The morphology of the
ECG indicates if the heart is contracting properly and driving blood flow sufficiently.
Humans and rats have remarkably similar cardiovascular anatomy, although a
rat’s ECG (figure 1.3) has subtle differences in waveforms and a faster rate. Each
waveform in the rat’s ECG represents the same fundamental mechanical process as
in the human heart. A rat’s typical HR ( 5Hz) is about five times greater than a
human’s ( 1Hz), thus each waveform in the rat’s ECG is significantly shorter than a
corresponding human.
Like a human heart, a rat’s heartbeat is not metronomic, but contains some small
variability between each beat on the order of milliseconds (figure 1.3). This difference
in successive periods of heartbeats is known as heart rate variability (HRV).
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Fig. 1.3 Rat ECG
Blood pressure refers to the amount of pressure (in mmHg) the blood is exerting
on the walls of the arteries. The American Heart Association (AHA) has published
guidelines for relative levels of blood pressure and their corresponding concern level
(figure 1.4) [2]. BP has become an essential in modern medicine to assess cardiovascu-
lar health. The AHA reports that “69 percent of people who have a first heart attack,
77 percent who have a first stroke, and 74 percent who have congestive heart failure
have blood pressure higher than 140/90 mmHg” [2]. Therefore, high blood pressure is
defined as having a systolic blood pressure (SBP) greater than 140 or diastolic blood
pressure (DBP) greater than 90 (or having a physician diagnosis you with high blood
pressure more than twice) [2]. Hypertension is estimated to be a cause of more than
10 percent of deaths worldwide, earning its title as the silent killer [2].
While HR and BP are central and integrated measures of cardiovascular health,
there remains many uncertainties. One or two measurements alone cannot adequately
summarize the cardiovascular health of an individual. Simple and noninvasive tests
that have normative measures facilitate clinical assessment and are in high demand.
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Fig. 1.4 American Heart Association guidelines for blood pressure categories [2].
Many new signal processing measurements have evolved including HRV analysis,
which can assess cardiovascular health within minutes using nothing more than ECG.
1.2 Role of the Autonomic Nervous System in Cardiovascular Homeosta-
sis
1.2.1 Branches of the Autonomic Nervous System
The brain and spinal cord make up the CNS, while all other neural tissues make
up the peripheral nervous system. In the peripheral nervous system, there are two
main divisions: somatic (voluntary actions) and autonomic. The ANS consists of all
automatic and non-voluntary functions. There are two main divisions of the ANS:
sympathetic and parasympathetic. A third division, the enteric nervous system, is
located in the gut and regulates gastrointestinal activity [10,11]. Its function is con-
sidered mostly independent or separate from the sympathetic and parasympathetic
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branches and as such is beyond the scope of this thesis. A diagram visualization of
the categorical branching of the nervous system is provided (figure 1.5).
Fig. 1.5 Nervous system diagram.
The sympathetic and parasympathetic divisions of the ANS present a unique func-
tion and physiology. The sympathetic nervous system (SNS) is responsible for arous-
ing the body to respond to a situation, while the parasympathetic nervous system
(PNS) is responsible for calming the body and restoring its resources. The coopera-
tion of these branches indicates how appropriately the nervous system is functioning
and thus is a central concern in assessing cardiovascular health.
1.2.2 Homeostasis and Control in the Cardiovascular System
Homeostasis is a dynamic state of equilibrium and practically defined as the body’s
inclination toward maintaining a healthy internal environment [11]. To achieve this,
the body relies on a large series of feedback pathways that communicate with the
CNS and this is schematized in figure 1.6 [8, 11].
These feedback pathways operate at different rates and manifest in many forms
including mechanical, chemical, and electrical. The fastest known communication
pathways in the body are neurogenic, i.e., electrochemical [8, 11]. These pathways
are composed of axons (highly conductive nerve tissue) and can respond to stimulus
in less than a second. Other feedback pathways utilize hormonal and slower internal

















Fig. 1.6 Control system viewpoint of feedback loops in the autonomic nervous
system (adjusted from [8]).
any given feedback cycle is reflected by the physical type of pathway utilized in that
cycle.
These networks of feedback pathways provide the body with high levels of inte-
grated control. Overall, the pathways sum to form a closed loop negative feedback
structure in the CNS [8,11]. The dorsal root and cranial nerve ganglia have numerous
sensory fibers that communicate with the CNS, which causes the CNS to generate
necessary corrections to return the body to homeostasis [8, 11]. These fibers are the
afferent inputs to the CNS, while their correlating effects to the system are the effer-
ent outputs. This constant stream of information going through afferent and efferent
channels among all the organs and the CNS creates an on-going oscillation, referred
to as sympathovagal balance.
1.2.3 Sympathovagal Balance
The term sympathovagal balance refers to the overall autonomic state the body is
in as a result of the influences from the SNS and PNS working simultaneously [12–24].
By functioning together with nearly reciprocal purposes, there is a constant oscillation
of the body’s autonomic state that is centered around a relative homeostatic plane
[8, 11–24].
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The simplified end function of the SNS is often to arouse the body, commonly
referred to as the ‘fight or flight’ response. The simplified end function of the PNS is
to drive the body back to homeostasis, often referred to as ‘rest and digest’ [8,10,11].
When either branch changes in activity, the other branch responds, creating a new
level of sympathovagal balance [8, 11].
New, relative homeostatic levels can arise from different underlying autonomic
states. For instance, someone that is at rest has a significantly different autonomic
tone than someone that is performing any form of exercise [16, 22, 25–30]. Exercise
actively promotes blood flow through the heart, skeletal muscles, and lungs. When
someone is eating, there is more blood flow to the digestive system. During rest,
blood flow is focused to the kidneys and gastrointestinal system. These blood flow
transitions require significant shifts in ANS. Yet, it can be expected that HR and BP
will be at levels appropriately matched to cardiac demand. In other words, the level
of energy that is exercised in the SNS and PNS could be relatively low, medium, or
very high, but the body can remain in a balanced state [11, 25]. This demands the
necessity of being able to evaluate the ANS so that the intricacies of the underlying
tone of the ANS can be interpreted accurately.
1.2.4 Clinical Assessments of the Autonomic Nervous System
To assess the ANS and quantify its function, it is necessary to compare a measured
variable and compare it to a perturbed one [8, 11, 25]. Analyzing the reaction of
the ANS in response to an isolated perturbation allows a specific reflex or feedback
pathway to be quantified. In order to stimulate the ANS, numerous tests have been
developed over time for use in the clinical setting [25]. These tests fall in one of two
categories: mechanical or chemical.
Mechanical assessments of the nervous system aim to promote the natural response
of the ANS without introducing any foreign chemical agent. Mechanical interventions
can be invasive in some cases, such as the innervation or denervation of nerve tissue
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[7, 25, 30]. Less invasive mechanical tests include tilt table, deep respiration, and
more [6, 11, 13, 14, 16, 17, 19, 20, 22, 26–29, 31–39]. In each of these tests, one or more
variables, such as HR or BP, is perturbed to assess the body’s cardiovascular response.
For example, the tilt table test involves having a patient flipped upside down on a
motorized table while their ECG and BP are constantly monitored. Blood flow to the
brain and heart rate are temporarily slowed, which causes a compensatory response
in the CVS that can be quantified to diagnose the patient. This is often done to find
the cause of a patient’s syncope (fainting). It also produces perturbations in HRV
and has significant effects on the overall time series of the ECG. Therefore, there is
demonstrated efficacy of using HRV as an additional measure of ANS function in the
clinical setting [6,7,13,16,18–24,27,29,32,36,38,40–43]. However, since many factors
contribute to HRV, it is necessary to construct more tightly controlled tests where
the perturbation in the ANS can be localized to specific feedback pathways, such as
the BRx, to limit potential bias in the quantification techniques.
Chemical or pharmaceutical tests of the nervous system aim to promote a response
of the ANS without mechanical means. Certain drugs are utilized in a clinical setting
for testing the ANS because of their limited risks and high efficacy. These include
nitroglycerin, phenylephrine, and others [12,14,17,18,25,30,31,38,44–52,52,53]. Ni-
troglycerin is often used during a tilt table test because it induces vasodilation, which
reduces BP and can elicit syncope. Phenylephrine is an alpha-adrenergic agonist,
meaning it mimics the effects of activating the SNS. It increases HR and BP im-
mediately, forcing the CVS to compensate and bring the system back into balance.
However, its powerful drive is not localized just to the BRx when it forces activation
of the SNS. This is a common drawback of most chemical tests, and it creates sig-
nificant variance and uncertainties in data, making it particularly difficult to justify
as a robust clinical measurement [7, 17, 18, 47, 48]. Nonetheless, chemical means are
effective at activating autonomic perturbations as to assess cardiovascular function.
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1.2.5 The Baroreflex – A Rapid Controller of Heart Rate and Blood
Pressure
The BRx is the primary negative feedback loop controller in charge of maintaining
homeostasis of the CVS [8, 11, 23, 25, 39, 53–56]. Baroreceptors are mechanoreceptors
– they respond to physical stretching. When BP changes, it causes the baroreceptors
to fire action potentials along axons [8, 11]. These action potentials are afferent
information, as they go to the nucleus of the solitary tract in the CNS to be integrated
by CNS structures [8]. After integration, the nucleus of the solitary tract sends
an efferent drive through sympathetic and parasympathetic efferent nerves. The
parasympathetic drive is fast enough to reach the effector organ (the heart) before
the next heart beat occurs, allowing it to slow the autonomic pacing cells in the
sinoatrial node and decrease the HR in a single heart beat [8, 11,25,36,55].
One of the most useful quantifications of the ANS is baroreflex sensitivity (BRS).
BRS is a method that assesses the gain of the BRx [25, 39, 45, 53–56]. BRS is de-
fined as “the change in interbeat interval in milliseconds per unit change in blood
pressure” [57]. This is measured in milliseconds per millimeters of mercury. This
measurement directly quantifies how fast and by how much the BRx is able to change
the HR in response to a given change in BP. BRS requires a patient’s ECG as well
as their simultaneous BP profile. Techniques like BRS provide useful measurements
for quantifying the ANS because of their practical clinical requirements.
1.2.6 The Autonomic Nervous System’s Control of Homeostasis
When a problem or perturbation is introduced to the ANS, the disparity between
the desired homeostatic plane and the feedback of the target organ are summed in the
CNS and to a large extent this sensory integration begins at the level of the nucleus
of the solitary tract [8]. This integration quantifies the error in the system (how far
away from normal the target organ is). To regain balance, the CNS generates an
efferent drive to compensate for the afferent response. However, because any given
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perturbation likely effects multiple organs, which are integrative and cooperative,
there is never a simple final solution [8, 11].
The SNS and PNS are constantly in a ‘push and pull’ relationship, causing never
ending oscillations in the cardiovascular branch of ANS [11]. This represents a sinu-
soidal steady state model where relative overall power in the system is maintained.
1.3 Heart Rate Variability
1.3.1 Understanding Heart Rate Variability
Sympathovagal balance directly affects the sinoatrial node, which controls the
timing of every cardiac cycle and imparts slight variations between heartbeats in a
healthy heart’s rhythm (figure 1.3) [13]. Furthermore, the lack of HRV in an individual
has been proven to have prognostic value in that there is a strong correlation in
ANS rhythmicity and sudden cardiac death [58]. Thus, research into HRV is rapidly
expanding, with a recent PUBMED title search of ‘heart rate variability’ yielding
nearly 26000 publications from the last 50 years. Numerous methods for HRV have
been developed, but they contain serious caveats that need to be addressed.
1.3.2 Techniques to Quantify Heart Rate Variability
Two main categories exist for quantifying HRV: time domain analysis and fre-
quency domain analysis [14,17,19,24,41,42,59]. In both methods, the objective is to
quantify sympathovagal balance. More specifically, the ideal measurement quantifies
both the discrete and combined contributions of the SNS and PNS on the sinoatrial
node.
Time domain analysis is rooted in measuring and understanding the time series
vector of successive heart beats. In analyzing the time period for each heartbeat,
there are several trends and correlations that reflect autonomic influence. Some of
the most common time domain techniques include RMSSD, SDNN, pNN50, and more
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[13, 41]. Each measurement quantifies a behavior or trend of the heartbeat intervals
within a short time span. With humans, time domain techniques usually utilize
between two and five minutes of ECG data, or approximately 120-300 periods of
heart beats [14, 17, 24, 41, 59]. In nearly every time domain measurement technique,
the fundamental assumption is that contributions of the SNS tend to increase HR
(because its serves to arouse the nervous system), while contributions of the PNS tend
to decrease HR (because it serves to restore the system) [17,30]. This statement is an
oversimplification, although it is well understood that these contributions reflect the
fundamental mechanisms of the ANS to a certain extent. There are many exceptions
to these assumptions, which is in part why frequency domain analysis has also evolved.
Frequency domain analysis aims to quantify the fundamental frequencies of the
ANS that are responsible for HRV [13, 17, 21, 24, 41]. Each successive heartbeat has
a different period that, when considered with neighboring heart beats and the over-
all R-to-R time series vector, corresponds to quantifiable frequencies. In order to
quantify these frequencies, a Fourier transform is utilized, which fundamentally will
transform any time series into corresponding frequencies. In the case of HRV, the
objective is to quantify the frequencies coming from the SNS and PNS, respectively.
One of the advantages of analyzing HRV in the frequency domain is that different
regions of the frequency power spectrum have been demonstrated to be correlated to
the sympathetic and parasympathetic branches [13, 17, 21, 24, 41]. There is a defined
region of low frequencies (i.e. the low frequency band) that was initially demon-
strated to be highly correlated with sympathetic tone. However, more recent studies
have suggested that the low frequencies are not reflectively of only sympathetic tone.
There is an adjacent region of higher frequencies (the high frequency band) that has
been demonstrated to be correlated to parasympathetic tone. By measuring these
frequency regions, sympathovagal balance can be quantified.
By assessing the fundamental frequencies of the ANS, frequency analysis quanti-
fies the level of integration and control in the ANS. The generated frequency spectrum
reveals not only at what frequencies the mechanisms occur, but also at what magni-
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tude each relative frequency is occurring. This significantly extends the opportunity
for understanding the underlying mechanisms at work in the ANS and allows for
experimental tests of the ANS to be quantified in physiologically specific context.
However, while inviting the opportunity for specific quantification of the ANS, the
frequency domain methods utilize certain assumptions that bring about potential
disadvantages.
It is important to understand and justify the assumptions that are utilized in fre-
quency transformations in the context of the experiment. Some of the most common
frequency domain techniques used in HRV analysis are the Fast Fourier Transform
power spectral density interpretation (FFT and PSD), AR modeling, wavelet trans-
formations, and the STFT [13, 17, 21]. Each frequency method utilizes one or more
unique assumptions when transforming the time domain into the frequency domain.
For instance, the FFT and PSD assumes that the transformed time series is both
stationary and periodic. Stationarity demands that the initial time series is in steady
state, or that any given portion of the series is equivalent to another randomly selected
portion. In the time domain, this suggests that the pattern of variance in the time
domain is relatively consistent, versus being completely random. The assumption of
periodicity implies that the given time series is evenly sampled and is repetitive as
a quantifiable function. These assumptions are not necessarily utilized in the other
frequency domain techniques, although they do utilize other assumptions. FFT and
PSD is utilized as the HRV analysis technique in this thesis, because it is believed that
the utilized animals (Sprague-Dawley rat breed) were in cardiovascular homeostasis,
which implies stationarity. In order to accomplish this, it was necessary to consider
several variables in every animal.
1.3.3 Variables to Consider in Heart Rate Variability
Because the CNS integrates the input of countless variables, it necessary to con-
sider how each variable affects HRV analysis. Variables known to influence HRV
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include HR, BP, respiration rate, tidal volume, age, sex, and more [11,19,24,41]. The
experimental protocol in this thesis carefully monitors and at least partially controls
for all of these variables. For example, the utilized anesthetic, urethane, is believed
to not bias the ANS or perturb cardiovascular homeostasis, while still establishing
a sufficient depth of anesthesia. With the consideration that there are potentially
countless confounding variables in HRV analysis, it is necessary to employ fundamen-
tally robust techniques in analysis, namely consistency. Because every technique has
its flaws, being consistent in a measurement method is crucial. In this thesis, the
experimental protocol was replicated in every experiment as closely as possible.
1.3.4 Clinical Concerns of Heart Rate Variability Analysis
Demonstrating the validity and usefulness of HRV techniques is essential for them
to be considered in the clinical scenario. Thus, one of the main focuses of HRV
research in the last few decades has been to demonstrate its robustness in quantifying
the ANS in response to a perturbation.
Mechanical techniques have been demonstrated to directly correlate to autonomic
activity. Less invasive tests such as the aforementioned tilt table test, as well as
highly invasive tests, such as sinoaortic innervation or denervation, have been shown
to cause significant effects in HRV analysis [13, 17, 20, 25, 28, 31, 34, 51]. Chemical
techniques, such as phenylephrine infusion, also correlate to autonomic activity and
have measurable effects on HRV analysis. However, there is significant variance in
the data, partially attributable to the caveats of HRV analysis. Regardless of the
technique for assessing HRV, research indicates the need to justify HRV analysis
based on the context of the experiment.
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HRV analysis has been around since 1960s, but no single technique has risen to
become the ‘gold standard’. This demonstrates a strong underlying concern in studies
for how to best utilize and perform HRV analysis. Furthermore, it implies a clear
need for establishing a better understanding of how to properly implement this signal
processing technique before it can become fully accepted as a robust and practical
clinical measure.
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1.4 Summary of Thesis Objectives
There are four primary objectives of this thesis.
1. Develop a tool for analysis of HRV capable of quantifying HRV in the presence
of selective and sustained electrical activation of the BRx.
2. Using frequency power spectrum of HRV to assess BRx function in male and
female rats.
3. Explore potential associations between BRS and HRV.
4. Refine experimental techniques and measurements to establish practical guide-
lines for future experimental protocols investigating HRV and BRx.
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CHAPTER 2. MATERIALS AND METHODS
2.1 Introduction
All animal experimental protocols were authorized by the Institutional Animal
Care and Use Committee at the Purdue School of Science for IUPUI (protocol no.
278R). A total of 40 Sprague Dawley Rats were utilized consisting of 26 males (Av-
erage Weight: 303 +/- 46.9 g; Average Age: 68.5 +/- 11.5 days) and 14 females
(Average Weight: 241 +/- 33.2 g; Average Age: 78.3 +/- 10.7 days). This age range
is consistent with previous research in the Schild Laboratory investigating sexual di-
morphism of the rat BRx [8]. The rats are old enough to obviate concerns regarding
ontogenetic factors that may bias reflex function such as sexual maturity and extent
of myelination [8,11] and yet young enough to facilitate dissection of autonomic nerves
of the neck. The CVS of the rat is physiologically similar to that of human and ex-
hibits much the same dynamic characteristics of autonomic reflex control of the heart
and circulation. Furthermore, unique to rats there exists an anatomically distinct
afferent nerve trunk that consists of solely mechanosensory fibers (baroreceptors).
Termed the aortic depressor nerve (ADN), these stretch-sensitive afferents convey a
powerful parasympathetic drive of the arterial BRx. Recent work in the Schild lab
has demonstrated a unique difference in myelinated baroreceptor fiber distribution
between male and female rats that significantly augments the baroreflex in females as
compared to age-matched males [8]. An overarching hypothesis of this thesis research
is that sexual dimorphism may also be apparent in HRV arising from the magnitude
and phase of afferent sensory feedback. All animal preparations were consistent with
those of earlier research in the Schild lab and only briefly described here [8]. The sole
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exception concerned the ADN stimulation protocols which were modified to provide
data records of adequate duration and control reference for precision HRV analysis.
2.2 Animal Preparation Protocol
Upon arrival at the vivarium, animals were allowed to accommodate for at least
one day before use in an experiment. Following transport to the laboratory, the rat
was exposed to the volatile anesthetic isoflurane (Henry Shein) within a sealed in-
duction chamber. Once lightly anesthetized, an intraperitoneal (IP) injection of an
anesthetic solution consisting of urethane (200 mg/mL; Ethyl Carbamate 97%, Argos
Organics) and alpha chloralose (10 mg/mL; AT, Sigma Life Sciences) was adminis-
tered (dosage: 0.8mL/100g). This combination of urethane and alpha chloralose has
long been shown to provide a stable plane of surgical anesthesia without significantly
altering autonomic control of the heart. A surgical plane of anesthesia was considered
established when the rat lacked reflex response to a noxious stimulus such as tail and
toe pinches.
2.3 Surgery Protocol
The surgery protocol consisted of 3 major stages: 1) tracheotomy, 2) catheteri-
zation of the left femoral artery and 3) blunt dissection of the left aortic depressor
nerve.
2.3.1 Tracheotomy
A tracheotomy helps the animal to breath which is particularly important as it
is unnatural for a rat to be in a supine dorsal recumbent position. A small 1-2 cm
midline incision was made on the ventral side of the neck just above the trachea. The
underlying musculature was bluntly dissected to provide access to the trachea which
was freed from surrounding tissues. A small incision was made in one of the cartilage
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rings just below the larynx and a tracheal tube was inserted and secured with suture.
The animal was allowed to breath spontaneously while the balance of the surgical
protocol was completed. If the animal showed signs of respiratory distress, then a
small animal respirator (Harvard Apparatus Model 683) was utilized.
2.3.2 Catheterization of the Left Femoral Artery
Inserting a catheter into the artery allows for continuous recording of arterial
pressure. A one-centimeter segment of the left femoral artery was isolated with blunt
dissection. The artery was pulled into tension to temporarily stop blood flow. Lido-
caine (2%; Henry Schein) was then dripped onto the vessel to relax the arterial smooth
musculature, thus dilating the artery which facilitated the entry of the catheter. A
small cut was made (1-2 mm) into the artery and the catheter (PE 50; Sublite) was
inserted and secured with suture. The catheter was prefilled with heparinized saline
(30 U/mL; Sagent Pharmaceuticals). After insertion, the blood pressure transducer
(Radnoti, CA) was connected to the catheter.
2.3.3 Isolation and Stimulation of the Aortic Depressor Nerve
Access to the left ADN allows for selective activation of the BRx. Blunt dissection
was performed lateral to the trachea. The ADN trunk is about 100 micrometers or less
in diameter and lies within the skeletal musculature of the neck. Running parallel
between the carotid artery and the vagus nerve and often comingling with a fine
sympathetic nerve trunk, the ADN cannot reliably be identified visually. Therefore,
a short duration suprathreshold electrical stimulus is applied to the dissected nerve
trunk to confirm control of reflex function. A bipolar hook electrode (PBAA0875,
FHC) attached to a micromanipulator (M3301R, World Precision Instruments) was
used to suspend the ADN and deliver electrical stimulation (continuous pulse train;
50Hz, 5 seconds, 250 microsecond pulses, 2V). A rapid and acute depression of arterial
BP (approximately 30-60 mmHg over 5-10 seconds) confirmed the dissected nerve
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trunk was the ADN. Following confirmation, the interface with the hook electrode
was coated in a mixture of Vaseline and mineral oil, allowing the nerve to remain
hydrated and limit interstitial fluid diffusion that would short the electrode contacts.
2.4 Transition Period
Heart rate, BP, and respiration were continuously monitored. Because the exper-
imental protocol is autonomically stressful, a transition period (30 minutes - 2 hours)
was often necessary before proceeding with the experimental protocol. This involved
waiting until the HR and BP returned to the defined stable range (4-6 Hz and 100
+/- 10 mmHg, respectively).
2.5 Controlling Respiration
Tidal volume and respiration are well known to effect HRV because of the auto-
nomic neural circuitry that underlies RSA [19, 42, 60]. The cyclical acceleration and
deceleration of HR produces a frequency peak in the power spectrum at the respi-
ration rate. The respirator (63 breaths per minute, 1.25cc) was used to control the
rat’s respiration after a natural-breathing baseline of ECG and BP was recorded. A
transition period (10-30 minutes) was given for the rat to adjust to the respirator
before proceeding to the stimulation protocol.
2.6 Stimulation Protocol
Following a baseline recording of spontaneous respiration, the continuous stimu-
lation protocol was carried out, consisting of 10 minutes of 5 Hz bipolar electrical
stimulation (2V regulated, 250 microsecond pulse width) of the left ADN. The pro-
tocol was repeated if the animal regained stability after stimulation.
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2.7 Timeline and Order of Experiment
A timeline for the experimental protocol is given in Table 2.1.
Table 2.1 Timeline of Experiments
Preparation Step Time Required
(Range in Minutes)
Anesthetic Preparation 30







There were three main segments during which the HR and BP were recorded for
analysis with the HRV algorithm:
1. A baseline recording taken during the stabilization period during which the
animal was breathing spontaneously (26 males; 14 females).
2. A baseline recording taken after the animal adjusted to the respirator, immedi-
ately preceding the stimulation of the ADN (3 males; 3 females).
3. A stimulation recording taken during the electrical stimulation of the ADN (3
females).
2.9 Inspection of ECG
ECG abnormalities can have significant effects on HRV [13,17,19,33]. Abnormal-
ities include any irregular heartbeats that are caused by an underlying problem with
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the heart’s electrophysiology. For example, there are arrhythmias that arise because
the heart has become dissociated from the sinoatrial node [61]. This can cause the
heart to lose active ANS pacing and a healthy and controlled rhythm. This has been
shown to have several repercussions in the ANS. For example, atrioventricular disso-
ciation is a condition where the sequential pathway between the atria and ventricles
is temporarily lost [61]. This results in the ventricles contracting independently of
the sinoatrial node. This can cause problems in the cardiovascular system’s ability
to meet hemodynamic demands. As a precaution against such data bias, each ECG
record was visually inspected to ensure that no apparent abnormalities were recorded.
If any abnormalities were found, the data was not used. Relatively common (about
5-10% of ECGs inspected in this thesis) abnormalities included premature ventricular
contractions, indicated by an R wave that occurs sooner than it should.
2.10 Development of Heart Rate Variability Analysis Algorithm
MATLAB 2019a was used to build the heart rate variability analysis algorithm
utilizing Welch’s method and power spectral density conversion. This algorithm in-
volved 10 major steps (figure 2.1), further detailed below.
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Fig. 2.1 Block diagram of the ten steps used to create the HRV algorithm.
Specifications meet or exceed those established as acceptable for HRV [19].
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1. Reading in the ECG Data - The ECG, BP, and stimulation data were recorded
with a sampling rate of 10k using a proprietary software package (Mr. Kick)
for easy import into MATLAB. HRV analysis assumes that the timing of each
heartbeat (the R wave) is detected exactly. A sampling rate of two hundred
times the heart rate is acceptable for HRV [19]. A higher sampling rate has no
disadvantages. The utilized sampling rate of 10k is approximately two thousand
times the heart rate of a rat, satisfying this requirement.
2. Selecting a Ten-minute Segment of Data - Data profiles could be as long as 120
minutes. The entirety of each data set was inspected to find the most stable
ten-minute portion. Mean HR was required to be 4-6 Hz and mean BP was
required to be 100 +/- 10 mmHg. Because the BP profile had considerable
variance in each surgery with respect to its detected peak to peak amplitude
(resulting from cyclic systolic and diastolic transitions), the DC average was
used to assess stability (figure 2.2). Respiration rate during that segment was
measured by performing an FFT on the BP profile (figure 2.3). The respiration
rate was required to be 1+/- 0.4 Hz. Two to five minutes of data are typically
used for HRV analysis in human and rats [14,17–19,30,47,48]. Because Welch’s
method is utilized for HRV analysis in this thesis, ten-minute segments were
selected to (a) verify animal stability, (b) increase signal resolution, and (c)
mitigate any potential signal-processing noise. Further explanation is given
below.
(a) If an animal is stable for a ten-minute segment, then it is a strong justifi-
cation that the signal is stationary.
(b) Approximately 3000 heartbeats (assuming 5 Hz HR) are contained within
ten minutes, compared to half or less than half that many in a two to five-
minute segment. This allows the FFT resolution (proportional to 1/num-
ber heartbeats) to be much better in preparation for accurate integration
of the power spectrum.
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(c) Any signal processing errors (such as arbitrary start and stop times) are
attenuated proportionally to the length of the data in a FFT.
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Fig. 2.2 Typical blood pressure profile recorded during a natural breathing baseline
in a male rat. The systolic and diastolic transitions (lower graph) varied
significantly in experiments, so the DC offset was used to quantify an average.
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Fig. 2.3 Typical power spectrum of a blood pressure profile taken from a male rat.
Respiratory sinus arrhythmia causes a sharp peak to occur that indicates the
animal’s respiration rate.
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3. Detecting ECG R Peak Locations with Windowing - The findpeaks windowing
toolbox was utilized to locate the time stamps of every R wave. In addition
to the basic local maxima that is utilized in this function, three more criteria
were used: minimum peak distance, minimum peak prominence, and minimum
peak height. Minimum peak distance varied from 100 to 150ms. Minimum peak
prominence varied from 0.15 – 0.8 V. Minimum peak height varied from -10 to 2
V. In 90% of the ECG profiles, minimum peak distance was 150ms, minimum
peak prominence was 0.15 V, and minimum peak height was -1 V. In some
cases, more uniquely tethered parameters were required. Heart rate variability
only considers the time locations of the R peaks in an ECG profile. Therefore,
any ECG that had distinguishable R waves could be used (figure 2.4).
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Fig. 2.4 Example ECG taken from a male rat. The algorithm marks the maximum
of each R wave and collects the associated time stamps, necessary for generating the
RRI time series vector.
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4. Generating RRI Vector - After collecting the time stamp of every R wave, the
RRI vector was generated by finding the difference between every adjacent R
wave (figure 2.5). For instance, the first RRI vector point was the time stamp
of the second R wave subtracted by the time stamp of the first R wave. The
second point was the 3rd R wave subtracted by the 2nd R wave, and so on.
 
Fig. 2.5 Demonstration of marked R waves used to generate RRI vector.
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5. Generating Averaged Time and Spline Interpolation Axes - To satisfy the peri-
odicity requirement of an FFT, the to-be transformed function must be periodic
and evenly sampled. To fulfill these requirements, the most popular method is
to perform spline interpolation and resampling [19]. A reference axis and new
arbitrary resolution axis need to be created to perform spline interpolation in
MATLAB. In this case, the arbitrary axis is time. The reference time axis was
calculated by averaging the time stamps between every two successive R waves
(figure 2.6). The new arbitrary axis was created with a starting point of 0 and
an endpoint equal to the last averaged time stamp value of the RRI vector, with
a resolution of 1/5000 s.
 
Fig. 2.6 Demonstration of marked R waves used to generate averaged time axis.
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6. Creating a Spline Fit to the RRI vector - MATLAB’s spline function is utilized
for interpolation to produce a 3rd order spline of the RRI vector (figure 2.7).
This function uses the generated time and RRI vectors to interpolate the RRI
vector with the resolution of the spline interpolation axis.
 
Fig. 2.7 Demonstration of high resolution 3rd order spline fit that interpolates the
original RRI vector (5 second window).
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7. Low Pass Filtering and Removing DC Offset - To prevent possible signal alias-
ing, the interpolated RRI is run through a 2nd order low pass Butterworth filter
with 25 Hz cut off frequency. Also, the DC component is subtracted to elimi-
nate the zero-frequency peak. The DC component represents the average HR in
this case. The variability around the average HR is the focus of HRV analysis,
thus it is appropriate to get rid of the DC signal which can be interpreted as
unwanted signal noise.
8. Resampling the Interpolated RRI Vector - A loop extracts every 100th point
from the interpolated RRI vector, starting with the first point. By extracting
every 100th point of a signal with a 5000 times enhanced resolution, the signal
is resampled at a rate of 50 (5000/100) Hz. The new interpolated and resam-
pled vector is approximately 30,000 points, which will provide a high resolution
periodogram.
9. Performing FFT and Generating Power Spectrum - Welch’s method is a modi-
fied approach for generating spectral density approximations. Welch’s method
is computed using the Pwelch function. It splits a signal into as many segments
as possible, up to a maximum of 8 (approximately 30,000/8 points in each seg-
ment), with 50% overlap. Each segment has a Hamming window applied to it
to reduce high frequency noise. The periodogram is then calculated for each
segment, and each of the periodograms is averaged to generate one final pe-
riodogram. By averaging periodograms, signal noise (inconsistencies between
overlapping segments) is attenuated. The power spectrum is computed from




10. Integrating the Power Spectrum - MATLAB’s trapz function is used to calcu-
late the total power s2 within a frequency band on the power spectrum. This
function calculates the integral of the specified region using the trapezoidal
method.
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2.11 Analysis of Frequency Bands
In the PSD integration technique, certain adjacent frequency bands are defined
and the power in each is integrated for comparison. In humans, these frequency
divisions are commonly defined as being in a high frequency (HF) band of 0.4 Hz to
0.15 Hz and a low frequency (LF) band of 0.15-0.04 Hz. The high frequency band
indicates parasympathetic tone, and the low frequency band indicates sympathetic
tone (as aforementioned, the low frequency band is a less certain measure). As the
fundamental HR is higher in rat, the frequency bands are expanded proportionally.
The rat’s low and high frequencies are contained within 0.2-5 Hz [22,29,36,37,45,58,
62–64]. In this thesis, the high frequency band is defined as 0.6 – 2.4 Hz and the low
frequency was defined as 0.2-0.6 Hz (figure 2.8) which are consistent with previous
literature [19,58,63].
2.12 Respiratory Peak Analysis
Respiratory peak analysis takes advantage of respiratory sinus arrhythmia. The
respiration frequency is defined as the center frequency (fc), a symmetrical tolerance
band (α) on either side of it is defined and that region is integrated [42, 60]. This is
represented as total power equals fc +/- α (figure 2.9). The value of α was set to
10% and 5% of the amplitude of the respiration peak (e.g. 1 Hz respiration frequency
would be represented with 1 +/- 0.05 and 1 +/- 0.1 Hz integration band). These
values were chosen so that the respiration peak would always be fully included within
the measurement in every data set.
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Fig. 2.9 Typical power spectral density graph used in respiratory peak analysis
where the respiration frequency band is integrated according to fc +/- α.
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2.13 Heart Rate Variability Quantification
The power spectral density-based measurements considered for analysis are listed
below. These measurements were chosen because they are commonly utilized in HRV
analysis for rats and humans [13,14,18,19,21,42,47,60].
1. High frequency band absolute power – the total energy obtained from integrat-
ing the defined high frequency band of 0.6-2.4 Hz
2. Low frequency band absolute power – the total energy obtained from integrating
the defined low frequency of 0.2-0.6 Hz
3. Normalized low and high frequency powers – the total energy in the low and
high frequency band when normalized by dividing by the signals total energy
contained in both bands (normalized to 100%)
4. Respiratory Peak Analysis – the total energy in the frequency band defined by
the respiration peak as the center frequency with a given symmetrical tolerance
based on the frequency of the respiration peak, represented by fc +/- α
By comparing the results of each technique to the context of the experimental
protocol, the efficacy of each method was assessed.
2.14 Baroreflex Sensitivty Analysis
The objective of BRS analysis is to quantify the entirety of BP control system with
one numerical value. Although this is a great simplification, it provides significant
information about the ANS. The slope method was utilized to calculate BRS. A series
of two consecutive ascending and descending RRI and paired BP values were collected
during respirator controlled breathing baseline just before stimulation. These were
compared to similar measurements taken from near the end (9 minutes in) of the
immediately following stimulation. Linear regression analysis was performed on these
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values to generate a BRS value. This produced positive (ascending) and negative
(descending) BRS values.
2.15 Statistics
Statistical data analysis and representation were performed using OriginLab 2019b
software. T tests with the unequal variance assumption were utilized for comparing
males and females. Paired t tests were utilized to compare the respirator baselines




The overarching objective of this thesis is to use HRV to quantify the ANS dur-
ing selective activation of the BRx depressor response. It was hypothesized that the
previously assessed sexual dimorphism in selective activation of the BRx depressor
response could be quantified with HRV. The null hypothesis is that there is no quan-
tifiable association between selective activation of the BRx and HRV. Two commonly
used algorithms for HRV were built in MATLAB: frequency band and respiratory
peak analysis. These algorithms were used to generate periodograms of RRI vec-
tors. Frequency bands in the periodograms were integrated and compared to assess
differences in autonomic tone during spontaneous breathing, controlled breathing,
and stimulation of the ADN. Another objective was to compare HRV and BRS. The
utilized frequency domain methods for HRV were compared to slope method measure-
ments for BRS during chronic stimulation of the ADN to see if a precise correlation
existed between HRV and BRS values.
3.2 Assessing Baseline Stability
Because studies have indicated that differences in baseline stability may be the
cause of differences in nearly identical HRV studies [14, 17, 18, 47, 48], the accepted
range of baseline parameters for HR and BP was highly restricted. Consistent with
a previous Schild lab study [8], the average resting BP was 100.08 +/- 5.46 mmHg
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and 100.85 +/- 4.37 mmHg for males and females, respectively. The average resting
HR was 5.34 +/- 0.60 Hz and 5.23 +/- 0.41 Hz for males and females, respectively.
3.3 Research Aims
Aim 1: To quantify autonomic tone during selective activation of the BRx using
HRV analysis.
Aim 2: Exploring correlations between HRV and BRS.
3.4 Aim 1: Quantifying Autonomic Tone using Heart Rate Variability
Use of Welch’s method for HRV analysis was designed using existing algorithms
and signal processing techniques in MATLAB. This generated high resolution peri-
odograms from ten-minute ECG profiles. The 0.2 – 0.6 Hz (figure 3.1: red) LF region
and 0.6-2.4 Hz (figure 3.1: green) HF region were integrated to produce a total power
measurement. Since factors contributing to frequencies below 0.2 Hz (VLF band) are
not well understood, the VLF band was not considered in analysis.
The data in figure 3.1 is the periodograms from six rats collected during sponta-
neous breathing. The animals were believed to be stable based on their HR, BP, and
respiration rate (table 3.1).
Table 3.1 Animal Stability Parameters and Frequency Band Powers for Figure 3.1
Animal Mean HR Mean BP Respiration LF Power HF Power
(Hz) (mmHg) (Hz) (s2) (s2)
Male 1 5.44 99.7 0.96 1.61E-07 5.86E-07
Male 2 5.61 98.9 0.85 2.36E-08 2.36E-07
Male 3 6.03 100.0 0.95 3.25E-08 1.23E-07
Female 1 4.91 96.0 0.71 3.65E-07 2.35E-06
Female 2 5.60 101.6 0.77 4.32E-07 4.11E-07
Female 3 5.50 99.0 0.95 4.27E-08 1.69E-07
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Fig. 3.1 Periodograms from 3 male and female rats recorded during a spontaneous
breathing baseline analyzed with frequency band method.
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The first analysis looked at only baseline recordings taken during spontaneous
breathing. Even with very similar resting heart rates, BP, and stable respiration rates,
the animals had a wide range of LF and HF total power. Furthermore, these power
differences resulted from different underlying frequencies (figure 3.1). The total power
averages from all baseline recordings during spontaneous breathing were compared
(figure 3.2). There was no significant difference in mean LF power (p=0.41). There
was also no significant difference in mean HF power (p=0.17), although males had a
63% higher mean power.
Given this lack of significance, the stability of the animals was further considered
based on ECG histogram type. Specifically, in addition to highly stable HR, BP, and
respiration rate, only animals with apparent gaussian ECG histograms were consid-
ered (which will be referred to as gaussian data in this work), because a non-gaussian
ECG histogram can be indicative of a lack of stability [4]. This reduced n = 26 to n =
9, and n = 14 to n = 6, for males and females, respectively. Even with this gaussian
criteria, there was still no significant difference in the LF or HF bands between males
and females (figure 3.3). Because the substantial variance was suspected to contribute
to the lack of significance, the coefficients of variation (SD divided by the mean) were
compared (table 3.2). The coefficients of variation decreased in every measurement
in the gaussian data set compared to the non-gaussian data set, which correlated to
a smaller p value. In the gaussian data set, the differences in males’ and females’ HF
power was marginally insignificant (p = 0.052).
Because the absolute measures of frequency bands lacked significance regardless
of the added filter for a gaussian ECG histogram, normalization that was consistent
with literature [13,14,18,19,21,37] was performed by defining the total power as the
sum of the power in LF and HF bands and dividing each band by the total power.
This resulted in the sum of the normalized LF and HF bands equaling one (figures 3.4,
3.5). With this normalization, no significant difference between males and females
was seen in the LF (p=0.26) or HF (p=0.26) bands.
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LF vs HF Power in all Animals
LF HF
Fig. 3.2 Comparing LF and HF total power for 10 minutes of ECG data during
spontaneous breathing baseline. Animals are not discriminated based on ECG
histogram distribution type. Mean LF and HF power was higher in males (n=26)
than females (n=14). Integrated total powers (mean +/- SD, units are s2): Male LF
power = 4.22 +/- 5.16 E-07. Female LF power = 3.12 +/- 3.31 E-07. Male HF
power = 2.71 +/- 3.31 E-06. Female HF power = 1.66 +/- 1.46 E-06.
Following the procedure done with absolute measures, the normalized data sets
were further restricted to gaussian data. In the gaussian data, no significant difference
between males and females was seen in the normalized LF (p=0.12) or HF (p=0.12)
bands. There was no correlation between coefficients of variation and p values (table
3.3), but this is because the utilized normalization technique produces an equivalent
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LF vs HF Power in Animals with
Gaussian ECG Distributions
LF HF
Fig. 3.3 Comparing LF and HF total power for 10 minutes of ECG data during
spontaneous breathing baseline. Only animals with an apparent gaussian ECG
histogram distribution are included. Mean LF and HF power was higher in males
(n=9) than females (n=6). Integrated total powers (mean +/- SD, units are s2):
Male LF power = 3.88 +/- 4.71 E-07. Female LF power = 2.05 +/- 1.54 E-07. Male
HF power = 1.73E-06 +/- 1.59 E-06. Female HF power = 5.28 +/- 2.14 E-07.
p value. Normalizing the data decreased significance and increased relative variance
in the data.
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Table 3.2 Comparing Coefficients of Variation to P values for Males and Females
ECG Histogram Sex Frequency Band Coefficient of P Value
Distribution Variation
All (figure 3.2) Male LF 1.22 0.41
Female LF 1.06
All (figure 3.2) Male HF 1.22 0.17
Female HF 0.87
Gaussian (figure 3.3) Male LF 1.21 0.30
Female LF 0.75
Gaussian (figure 3.3) Male HF 0.91 0.052
Female HF 0.40
Table 3.3 Comparing Coefficients of Variation to P values for Males and Females
with Normalized Frequency Bands
ECG Histogram Sex Frequency Band Coefficient of P Value
Distribution Normalized Variation
All (figure 3.4) Male LF 0.46 0.26
Female LF 0.70
All (figure 3.4) Male HF 0.06 0.26
Female HF 0.14
Gaussian (figure 3.5) Male LF 0.50 0.12
Female LF 0.53













































Normalized LF vs HF Power in all Animals
LF HF
*
Fig. 3.4 Comparing normalized LF and HF total power for 10 minutes of ECG data
during spontaneous breathing baseline. Animals are not discriminated based on
ECG histogram distribution type. Mean normalized LF power was higher in females
(n=14) than males (n=26). Mean normalized HF power was higher in males (n=26)
than females (n=14). Integrated total powers (mean +/- SD, units are s2): Male LF
power = 0.13 +/- 0.06. Female LF power = 0.17 +/- 0.12. Male HF power = 0.86
+/- 0.06. Female HF power = 0.82 +/- 0.12.
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Fig. 3.5 Comparing normalized LF and HF total power for 10 minutes of ECG data
during spontaneous breathing baseline. Only animals with an apparent gaussian
ECG histogram distribution are included. Mean normalized LF power was higher in
females (n=6) than males (n=9). Mean normalized HF power was higher in males
(n=9) than females (n=6). Integrated total powers (mean +/- SD, units are s2):
Male LF power = 0.14 +/- 0.07. Female LF power = 0.26 +/- 0.14. Male HF power
= 0.85 +/- 0.07. Female HF power = 0.73 +/- 0.14.
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Because the normalization method did not demonstrate any significance, the res-
piratory peak (fc) analysis method was utilized to assess the power density spectrums.
A symmetrical (α = 10% and 5%) band centered on the respiratory peak was inte-
grated (figure 3.6: green; α = 10%) to obtain a total power value (table 3.4).
 
Fig. 3.6 Periodograms from 3 male and female (same animals as figure 3.1) rats
recorded during a spontaneous breathing baseline analyzed with respiratory peak
method.
The respiratory peak power from all baseline recordings during spontaneous breath-
ing were compared for α = 10% (figure 3.7). Males had a 52% higher mean power
than females, but there was no significant difference (p=0.35). The data sets were
then filtered to only gaussian data (figure 3.8). In the gaussian data, the males’ mean
respiratory peak power was significantly (p=0.02) higher (447%) than the females.
51
Table 3.4 Animal Stability Parameters and Respiratory Band Powers for Figure 6
Animal Mean HR Mean BP Respiration Power Power
(Hz) (mmHg) (Hz) α = 10% α = 5%
(s2) (s2)
Male 1 5.44 99.7 0.96 2.33E-07 2.18E-07
Male 2 5.61 98.9 0.85 1.68E-07 1.62E-07
Male 3 6.03 100.0 0.95 6.45E-08 6.09E-08
Female 1 4.91 96.0 0.71 1.27E-06 1.18E-06
Female 2 5.60 101.6 0.77 8.75E-08 6.36E-08
Female 3 5.50 99.0 0.95 2.12E-08 1.29E-08
To see the effects of different respiratory peak integration widths (the α value) in-
tegrated on the power spectrum, measurements were repeated for α = 5% (figures
3.9, 3.10). In the data set with all the animals, the means and variances were very
similar to the values from α = 10%, and there was no significant difference between
males and females (p=0.28). When the data was restricted to gaussian only, the
males’ mean respiratory band power was significantly (p=0.01) higher (496%) than
the females. For α = 10% and 5%, the gaussian data had a smaller relative variance,
greater significance (smaller p value), and smaller coefficient of variation (table 3.5).
52













































Respiratory Peak +/- 10% in all Animals
Fig. 3.7 Respiratory band total power for 10 minutes of ECG data during
spontaneous breathing baseline. Animals are not discriminated based on ECG
histogram distribution type. Mean respiratory band power was higher in males
(n=26) than females (n=14). Integrated total powers (mean +/- SD, units are s2):
Male respiratory band power = 1.52 +/- 2.36 E-06. Female respiratory band power
= 1.00 +/- 1.08 E-06.
After analyzing baselines taken during spontaneous breathing, baselines were an-
alyzed from respirator-controlled breathing. The fixed respiration rate of 62 bpm
expectedly (because of RSA) caused a large sharp respiration peak to occur at 1.03
(62/60) Hz on the power spectrum in most animals (figure 3.11). Some animals failed
to adjust to the respirator, causing multiple respiration peaks and/or other crisis
activity to be seen (figure 3.12), and were not considered for analysis.
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Respiratory Peak +/- 10% in Animals with
Gaussian ECG Distributions
*
Fig. 3.8 Respiratory band total power for 10 minutes of ECG data during
spontaneous breathing baseline. Only animals with an apparent gaussian ECG
histogram distribution are included. Mean respiratory band power was higher in
males (n=9) than females (n=6). Integrated total powers (mean +/- SD, units are
s2): Male respiratory band power = 7.07 +/- 1.98 E-07. Female respiratory band
power = 15.87 +/- 9.33 E-08.
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Respiratory Peak +/- 5% in all Animals
Fig. 3.9 Respiratory band total power for 10 minutes of ECG data during
spontaneous breathing baseline. Animals are not discriminated based on ECG
histogram distribution type. Mean respiratory band power was higher in males
(n=26) than females (n=14). Integrated total powers (mean +/- SD, units are s2):
Male respiratory band power = 1.53 +/- 2.27 E-06. Female respiratory band power
= 9.61 +/- 10.61 E-06.
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Respiratory Peak +/- 5% in Animals with
Gaussian ECG Distributions
*
Fig. 3.10 Respiratory band total power for 10 minutes of ECG data during
spontaneous breathing baseline. Only animals with an apparent gaussian ECG
histogram distribution are included. Mean respiratory band power was higher in
males (n=9) than females (n=6). Integrated total powers (mean +/- SD, units are
s2): Male respiratory band power = 6.50 +/- 5.24 E-07. Female respiratory band
power = 13.17 +/- 8.63 E-08.
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Table 3.5 Comparing Coefficients of Variation to P Values for Males and Females in
Respiratory Peak Analysis
ECG Histogram Sex Respiratory Band Coefficient of P Value
Distribution α Value Variation
All Male 10 1.55 0.35
(figures 3.7,3.8) Female 10 1.08
All Male 5 1.47 0.28
(figures 3.7,3.8) Female 5 1.10
Gaussian Male 10 0.28 0.02
(figures 3.9,3.10) Female 10 0.58
Gaussian Male 5 0.80 0.01







Fig. 3.11 Periodogram generated from a male rat that successfully adjusted to the
respirator, indicated by the single respiration peak centered at the respirator
frequency (1.03 Hz).
A total of 3 males and 3 females were used for respirator controlled breathing
baseline analysis. Analysis was performed using the previous procedures of absolute
power integration in the LF and HF bands (figure 3.13) and normalization (figure
3.14). In absolute measures, the variance in the males LF power was relatively low,
but there was no significant difference between males and females in either the LF
power (p=0.18) or HF power (p=0.62). A smaller coefficient of variation correlated to
a smaller p value (table 3.6). Normalizing the data (table 3.7) revealed no significance






Fig. 3.12 Periodogram from a male rat that failed to adjust to the respirator,
indicated by the a lack of a single respiratory peak at 1.03 Hz.
Table 3.6 Comparing Coefficients of Variation to P Values for Absolute
Measurements of Frequency Bands during Respirator Controlled Breathing
Sex Frequency Coefficient of P Value
Band Variation
Male LF 0.09 0.18
Female LF 0.67










































Baseline LF vs HF Power 
*
LF HF
Fig. 3.13 Comparing LF and HF total power for 10 minutes of ECG data during
respirator controlled breathing baseline. Two males had an apparent gaussian ECG
histogram, and one had an apparent bimodal. Two females had an apparent
gaussian ECG histogram, and one had an apparent bimodal. Mean LF and HF
power was higher in females (n=3) than males (n=3). Integrated total powers
(mean +/- SD, units are s2): Male LF power = 4.54 +/- 0.41 E-07. Female LF
power = 2.04 +/- 1.38 E-06. Male HF power = 5.06 +/- 3.84 E-06. Female HF
power = 6.69 +/- 3.53 E-06.
In the respirator-controlled breathing baselines, respiratory peak analysis (figure
3.15; α = 10%, figure 3.16; α = 5%) revealed no significant difference between males
and females for either α = 10% (p = 0.58) or 5% (p=0.52).
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Normalized Baseline LF vs HF Power 
LF HF
*
Fig. 3.14 Comparing normalized LF and HF total power for 10 minutes of ECG
data during respirator controlled breathing baseline. Mean normalized LF power
was higher in females (n=3) than males (n=3). Mean normalized HF power was
higher in males (n=3) than females (n=3). Integrated total powers (mean +/- SD,
units are s2): Male LF power = 0.11 +/- 0.07. Female LF power 0.21 +/- 0.09.
Male HF power = 0.88 +/- 0.07. Female HF power = 0.78 +/- 0.09.
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Table 3.7 Comparing Coefficients of Variation to P Values for Normalized
Measurements of Frequency Bands during Respirator Controlled Breathing
Sex Frequency Coefficient of P Value
Band Variation
(Normalized)
Male LF 0.63 0.22
Female LF 0.42
Male HF 0.09 0.22
Female HF 0.11









































Respiratory Peak +/- 10% 
Fig. 3.15 Respiratory band total power for 10 minutes of ECG data during
respirator controlled breathing baseline. Mean respiratory band power was higher in
males (n=3) than females (n=3). Integrated total powers (mean +/- SD, units are
s2): Male respiratory band power = 3.92 +/- 4.07 E-06. Female respiratory band
power = 2.42 +/- 0.52 E-06.
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Respiratory Peak +/- 5% 
Fig. 3.16 Respiratory band total power for 10 minutes of ECG data during
respirator controlled breathing baseline. Mean respiratory band power was higher in
males (n=3) than females (n=3). Integrated total powers (mean +/- SD, units are
s2): Male respiratory band power = 3.82 +/- 4.10 E-06. Female respiratory band
power = 1.99 +/- 0.80 E-06.
Table 3.8 Comparing Coefficients of Variation to P Values for Respiratory Bands
during Respirator Controlled Breathing
Sex Respiratory Coefficient of P Value
Band α Value Variation
Male 10 1.03 0.58
Female 10 0.21
Male 5 1.07 0.52
Female 5 0.40
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For analysis during selective activation of the BRx depressor response (chronic
stimulation of the ADN), a total of 3 females (on a respirator) were used. The
chronic stimulation resulted in an average decrease in HR of 0.14 +/- 0.30 Hz and
average decrease in BP of 34.00 +/- 15 mmHg (figure 3.17; top, middle), consistent
with a previous Schild lab study [8]. No males had successful chronic stimulation
trials due to various protocol issues, such as the electrodes shorting out during the
stimulation.
A respirator-controlled breathing baseline was used as a paired control for each
chronic stimulation in HRV analysis (figure 3.18). Because previous frequency band
analysis indicated no significance for absolute and normalized measurements, only
absolute measures of HF were compared for frequency band analysis because they
were marginally insignificant for gaussian data. Respiratory peak analysis was also
performed for α = 10% and 5%. In all measurements, there was an increase in average
power, despite no significant differences observed (HF: p=0.32; α = 10%, p = 0.19; α
= 5%, p = 0.28). The author would like to note that one of three data sets from the
stimulation trials was possibly an outlier, as its power density spectrum was highly
inconsistent compared to the other two stimulations and their paired baselines.
To further assess how HRV is affected throughout the duration of the stimulation
protocol, three five minute windows were analyzed using the HRV algorithm (adjusted
to analyze five minute intervals of ECG). These windows were taken at the beginning
(first five minutes), middle (middle five minutes), and end (last five minutes) of the
chronic stimulation (figure 3.17). There was a consistent decrease in LF and HF
power throughout the course of the stimulation.
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First 5 Minutes of Stimulation Middle 5 Minutes of Stimulation Last 5 Minutes of Stimulation
10 Minute Depressor Response (Chronic Stimulation)
RRI Histogram RRI Histogram RRI Histogram
LF Power  (s2) = 8.08E-06 
HF Power (s2) = 1.44E-05 
LF Power  (s2) = 4.41E-06 
HF Power (s2) = 8.64E-06 
LF Power  (s2) = 2.06E-06 
HF Power (s2) = 7.98E-06 
RRI Periodogram (First 5 mins)
RRI Histogram
LF Power  (s2) = 6.06E-06
HF Power (s2) = 1.11E-05
Chronic Stimulation RRI PeriodogramBaseline 10 Minute RRI Periodogram
RRI Histogram
LF Power  (s2) = 2.79E-06
HF Power (s2) = 6.27E-06
RRI Periodogram (Middle 5 mins) RRI Periodogram (Last 5 mins)
Blood Pressure Profile Blood Pressure Profile Blood Pressure Profile
Fig. 3.17 HRV analysis and blood pressure response during chronic stimulation. Ten
minute windows (top) are compared to a sliding five minute window (bottom).
Starting from the beginning and moving towards the end of the stimulation, there is
a consistent decrease in the power bands.
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HF Fc +/- 10% Fc +/- 5%





Fig. 3.18 R = Respirator Baseline. S = Stimulation. Comparing HF and respiratory
band power for 10 minutes of ECG data during respirator controlled breathing
baseline and its immediately followed paired stimulation. Mean power increased in
all cases. Integrated total powers (mean +/- SD, units are s2): HF R power = 6.69
+/- 3.81 E-06. HF S power = 8.76 +/- 3.12 E-06. α = 10% R power = 2.42 +/-
0.52 E-06. α = 10% S power = 3.07 +/- 1.11 E-06. α = 5% R power = 1.99 +/-
0.80 E-06. α = 5% S power = 2.38 +/- 1.23 E-06.
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To test if shorter durations, including the five minute windows analyzed during
stimulation, would be viable for HRV analysis, all previous tests were repeated using
five-minute-long ECGs (half the duration). These five minutes portions were taken
from the center of the ten-minute segments (going from 2.5 minutes to 7.5 minutes
in any ten-minute ECG’s recording). In all measurements with five minutes of data,
the only significant differences were those with significant differences from ten-minute
ECG HRV analysis (respiratory peak analysis for animals with gaussian ECGs, for
α = 10% and 5%). However, significance did increase for the five-minute recording
for both α values (table 3.9). It is worth noting that the five-minute measurement
comparing absolute HF measures between gaussian males and females had a p value
of 0.05001 (still marginally insignificant).
Table 3.9 Comparing P values for Respiratory Peak analysis for Ten and Five
Minutes of ECG Data





3.5 Aim 2: Exploring Correlations between Baroreflex Sensitivity and
Heart Rate Variability Analysis
BRS analysis was performed on the three females with paired respirator-controlled
breathing baselines and stimulations using the slope method. An ascending (two in-
creasing RRI and BP values) and descending (two decreasing RRI and BP values)
BRS value was calculated for the baseline recording immediately before the paired
stimulation, as well as nine minutes into the stimulation to mitigate transient effects.
There was no significant difference (p=0.45) between the paired baseline and stim-
ulation ascending BRS values (figure 3.19). There was also no significant difference





















































Fig. 3.20 Descending BRS values during baseline and stimulation for female rats.
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The BRS values were compared to the significant HRV measurements (respiratory
band power) from ten-minute respirator controlled breathing baseline (table 3.10)
and stimulation (table 3.11) recordings. These measurements were repeated for five-
minute recordings (tables 3.12, 3.13). There was no consistent correlation between
BRS values and the respiratory band power in any of the measurements for both ten
and five minutes. The author would like to note that female 3 (tables 3.10-3.13) is a
possible outlier.
Table 3.10 Comparing Baseline BRS Values to Respiratory Peak Analysis for 10
Minute ECG Recordings
Animal Ascending Descending Respiratory Respiratory
BRS BRS Band Power Band Power
(ms/mmHg) (ms/mmHg) α = 10% α = 5%
(s2) (s2)
Female 1 3.15 1.46 2.12E-06 2.04E-06
Female 2 0.26 1.01 3.03E-06 2.77E-06
Female 3 13.29 13.30 2.12E-06 1.17E-06
Table 3.11 Comparing Stimulation BRS Values to Respiratory Peak Analysis for 10
Minute ECG Recordings
Animal Ascending Descending Respiratory Respiratory
BRS BRS Band Power Band Power
(ms/mmHg) (ms/mmHg) α = 10% α = 5%
(s2) (s2)
Female 1 0.19 10.47 2.12E-06 2.04E-06
Female 2 3.07 1.25 3.03E-06 2.77E-06
Female 3 3.54 23.32 2.12E-06 1.17E-06
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Table 3.12 Comparing Baseline BRS Values to Respiratory Peak Analysis for 5
Minute ECG Recordings
Animal Ascending Descending Respiratory Respiratory
BRS BRS Band Power Band Power
(ms/mmHg) (ms/mmHg) α = 10% α = 5%
(s2) (s2)
Female 1 3.15 1.46 2.16E-06 2.07E-06
Female 2 0.26 1.01 3.33E-06 3.05E-06
Female 3 13.29 13.30 2.06E-06 1.09E-06
Table 3.13 Comparing Stimulation BRS Values to Respiratory Peak Analysis for 5
Minute ECG Recordings
Animal Ascending Descending Respiratory Respiratory
BRS BRS Band Power Band Power
(ms/mmHg) (ms/mmHg) α = 10% α = 5%
(s2) (s2)
Female 1 0.19 10.47 2.61E-06 2.33E-06
Female 2 3.07 1.25 3.68E-06 3.24E-06




This thesis investigated HRV techniques for quantifying autonomic tone. The FFT
and PSD frequency transform method was utilized because of its experimentally fit-
ting assumptions and persistent use in research. This work demonstrated that there
are strong correlations between the power spectrum of HRV and the ANS, particu-
larly with the appearance of the respiratory peak in the power spectrum. The most
prominent findings included: (1) there are many caveats involving cardiovascular
stability that affect HRV, which results in a large amount of variance in the con-
trol system and associated power spectrums; (2) frequency band analysis, with and
without applied normalization, is not consistently adequate for precisely measuring
a sexual dimorphism in HRV; (3) respiratory peak analysis is a precise measurement
that demonstrated sexual dimorphism in HRV; (4) there is a consistent increase in
HRV during sustained electrical activation of the BRx depressor response; and (5) the
slope method for BRS is likely not adequate for quantifying the BRx during sustained
electrical activation of the BRx depressor response.
4.2 Assessing Cardiovascular Stability
Many of the measurements in this work involved considering more stability param-
eters beyond just HR, BP, and respiration, with additional discrimination based the
ECG histogram distribution type (e.g. figure 3.2 versus figure 3.3) It is important to
note that this method does not simply remove outliers to demonstrate significance.
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Rather, this more strongly justifies the assumption of stationarity, which implies
strong cardiovascular stability. Furthermore, it removes a serious bias in the data
because non-gaussian ECG histogram distributions have more variability around the
mean than gaussian ones. Because HRV quantifies the variability around the mean
heart rate, a non-gaussian ECG histogram has higher magnitudes of power in the
power spectrum. This practice of more carefully considering viable data has been ex-
tensively utilized in recent HRV studies [24,41], whereby data sets for HRV in humans
is filtered down from tens of thousands of potential participants to hundreds based
on several parameters relating to cardiovascular health (medical history, drug use,
lifestyle, etc.). However, even with this additional criteria, there was still substan-
tial variance in the data, especially in the frequency band analysis. In the following
sections, the data that is additionally filtered based on having an apparent gaussian
ECG histogram will be referred to as ‘gaussian’ data.
4.3 Methods for Quantifying the Power Spectrum
4.3.1 Analysis Method 1: Quantifying Absolute Measures of LF and HF
bands.
The first frequency band technique compared integrating the absolute power con-
tained in the LF and HF bands in the power spectrum between males and females.
Even with animals that had very similar stability profiles (table 3.1), the observed
power spectrums were often very different in overall power and specific frequency
peaks (figure 3.1). Because of this variance, it was not surprising that there was
no significant difference in the LF bands between males and females (figure 3.2). To
quantify this variance with respect to the mean power, the coefficients of variation for
the LF bands were calculated (table 3.2). The coefficients of variation were greater
than one, indicating a variance greater than the mean. This large amount of vari-
ance was observed in the HF band power too (figure 3.2; table 3.2), where males had
63% higher average HF power than females, but there was no significant difference
74
again. When the data sets were restricted to gaussian only data and compared, there
was still no significant difference in either the LF or HF frequency band (figure 3.3).
However, the HF band measurement with only gaussian data had a p value of 0.052,
down from 0.17, demonstrating the necessity in restricting the data to prevent a bias
based on the ECG histogram distribution.
Based on these findings of absolute measures in the frequency bands, the LF
band’s absolute power measurement is not precise enough to establish any difference
between males and females. This was not surprising, based on the continually grow-
ing uncertainty of what the LF band truly represents, beyond just sympathetic tone.
While the HF band also didn’t demonstrate any significant differences, even with the
added gaussian restriction, there is a strong possibility that with more ns, the gaus-
sian data would be significantly different between the sexes, based on the marginally
insignificant p value.
4.3.2 Analysis Method 2: Quantifying Normalized Measures of LF and
HF bands.
Since the absolute measures of the frequency bands had no significance, it was de-
termined that normalizing the data was worth performing, given the large variability
in the data. After normalizing the data (figures 3.4, 3.5) and repeating the frequency
band measures, there was still no significance, and the p value in the gaussian data
even increased (table 3.3). This was surprising, as this normalization technique is
often utilized in human HRV studies and often demonstrates significant differences
between males and females in the power spectrum [7,12, 17, 21, 34, 41, 47, 51]. It may
require significantly more data for the normalization technique to be adequate. It is
important to note that the normalization method biases the coefficient of variation
towards having a lower value, so it is not surprising that the p values were higher
despite a lower coefficient of variation as compared to the absolute measures of the
frequency bands.
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4.3.3 Analysis Method 3: Performing Respiratory Peak Analysis for α =
10% and 5%
It was hypothesized that respiratory peak analysis would be a more robust measure
of HRV than frequency band analysis because of its strong connection to the PNS,
whereby respiration is heavily modulated by activity in the vagal nerve. The α values
of 10% and 5% were chosen based on literature [42] and so at least two values were
available for comparison. Without restricting to only gaussian data (figures 3.7, 3.9),
there was no significance observed for either α value (table 3.5). However, the gaussian
data (figures 3.8, 3.10) was statistically significant for both values of α (table 3.5)
with p = 0.02 for α = 10% and p = 0.01 for α = 5%. This significance was expectedly
correlated to lower coefficients of variation (table 3.5). The lower α values had lower
p values, which is consistent with literature [42, 60]. Furthermore, this significance
implies that females have lower mean respiratory band power. This was surprising
because it well known that females have an overall more active parasympathetic
nervous system compared to males. Therefore, it was expected that the females’
respiratory band would contain more power than males. One possible explanation
for this is that the female’s more active PNS causes them to have more control,
and thus less error in the control system. The power spectrum ultimately quantifies
the variability in the time series of the RRI, so having a lower power indicates less
variations in the heart rate. By having a higher control over their PNS, females may
exhibit less HRV, and therefore have an associated smaller respiratory peak band.
The author is unaware of any studies that support this hypothesis, and it would
require more testing to demonstrate its veracity.
4.3.4 Analysis Method 4: Quantifying Frequency and Respiratory Band
Measures with Respirator-Controlled Breathing
When it was demonstrated that respiration had a significant effect on the power
spectrum, the author started to control for respiration with a respirator. This ad-
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justment came late in the experiments, and only six animals, three males and three
females, successfully adjusted to the respirator and could be used for analysis. Fre-
quency band analysis (absolute and normalized measures) as well as respiratory peak
analysis was performed on these six animals.
It was hypothesized that by controlling respiration, there would be more consis-
tency in the respiratory peak bands in the power spectrums. However, the opposite
occurred, where the data was even more variable in the absolute (figure 3.13; table
3.6) and normalized (figure 3.14; table 3.7) frequency band measurements. In the
normalized data, similar trends as before were observed, where the data became even
less significant.
In respiratory peak analysis, there was also no significance for both α= 10% (figure
3.15) and 5% (figure 3.16). However, females had a much lower coefficient of variation
than males (table 3.8), again suggesting that females have less HRV associated with
respiratory modulation. The author wishes to note that the low number of ns is likely
a contributor for the lack of significance, as the means were similar to those from the
spontaneous breathing baseline, which were highly significant measures in respiratory
peak analysis.
4.3.5 Analysis Method 5: Quantifying Frequency and Respiratory Band
Measures during Focal Parasympathetic Drive of the Baroreflex
By stimulating the ADN, there is selective activation of the BRx, which causes
significantly elevated activity in the PNS [8]. It was hypothesized that stimulation of
the ADN would cause increases in the power of HF band and respiratory peak power.
Three females were used in analysis, where each had a paired respirator baseline and
stimulation. The HF band (absolute measurement) and respiratory band (α = 10%
and 5%) were compared for each paired baseline and stimulation (figure 3.18). There
was an increase in mean power between the baseline and stimulation, but there were
no significant differences in any measurement. Furthermore, the decreases in HR and
77
BP were consistent with a previous Schild lab study [8]. These trends suggest that
more ns could demonstrate a significant difference. It would be surprising if HRV
could not measure any differences in autonomic tone during stimulation.
Five minute windows (figure 3.17) were analyzed throughout the duration of the
stimulation. There was an observed decrease in the LF and HF power moving from
the the first window to the second and third windows, respectively. This was an
interesting trend because it is expected that there will be more compensatory activity
during the first five minutes of stimulation when transient effects have a great effect,
relative to the end of the stimulation when the stimulated system is closer to or
in steady state. This experimentally fitting observation further suggests that HRV
analysis is sensitive enough to assess the transient effects of focal parasympathetic
drive, and that perhaps shortening the duration of the algorithm to assess five minute
intervals is appropriate (which would also be experimentally easier).
4.4 Shortening the Duration of the Data
By using ten-minutes of ECG data in all of the previous measurements, there is
a strong justification that the animals had reached sufficient cardiovascular stability
and satisfied the assumption of stationarity. However, it would be more useful to
implement HRV in the clinical setting if shorter ECGs were acceptable. To assess the
validity of shorter durations, all analyses were repeated with only five minutes of ECG
data, taken from the middle of the ten minute samples. In these measurements, it
was found that only the already significant measurements (respiratory peak analysis
for gaussian data) were significant. However, the p value did decrease with the five
minutes of data (table 3.9), suggesting that using five minutes or less of data is
sufficient for HRV in a rat, which widens the possibility of collecting data, as it easier
to establish shorter time spans of stability.
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4.5 Comparing Baroreflex Sensitivity to Heart Rate Variability Analysis
during Chronic Stimulation
The slope method of BRS was utilized because it is most commonly used in
the clinical setting after perturbing the ANS [19]. It was hypothesized that the
ascending and descending BRS values would correlate to the magnitude of the HRV
power spectrum. However, no correlation was observed and there was no significant
difference between baseline and stimulation for either ascending or descending BRS
values (figures 3.19, 3.20). There was no consistency between the magnitude of the
BRS value and the respiratory band measures taken from ten minutes (tables 3.10,
3.11) or five minutes (tables 3.12, 3.13) of data. The author believes this is due to the
low number of ns, as well as a potential outlier in the data set. It would be surprising if
BRS could not measure any differences in autonomic tone during stimulation because
of the already known significant correlation between the BRx and the ANS.
4.6 Future Considerations
Based on the observations of this work, there are seemingly at least three impor-
tant expansions in the data analysis to make:
1. Performing respiratory peak analysis for more values of α - studies have in-
dicated that lower values of α demonstrate increasing levels of significance,
although those studies are as restrictive in their use of data [42,60]. This trend
of significance persisted in this thesis, but utilizing smaller values than 5% for
α may cause some respiratory peaks to not be fully included in the measure-
ment, so a balance of optimization for how far α could be decreased while being
physiologically justified would have to be considered.
2. Using shorter than five-minute segments of ECG - HRV analysis is often done
with less than five minutes of data, and because there was strong significance
in five minutes of data for respiratory peak analysis, there is the possibility of
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continually decreasing the duration used while still being meaningful. While
this becomes more clinically practical, great caution would have to be given to
the consideration of stationarity. It would be easy to be deceived into thinking
an animal is stable based on a couple minutes of ECG and BP data. Therefore,
there is potential for quantifying what is the acceptable minimum duration of
data that should be used in the FFT and PSD method.
3. Using more extensive BRS techniques to quantify a correlation between HRV
and BRS - there are now dozens of techniques for quantifying BRS, which
like HRV, have many caveats. BRS analysis can become very sophisticated,
although each technique can be justified in the context of the experiment, like
HRV. It is known that there is a correlation in the physiology between BRx
activation and HRV, so there is likely a better method for assessing BRS than
the slope method utilized in this work.
Furthermore, it would be useful to see how other frequency domain techniques
compare to the FFT and PSD method during sustained activation of the BRx de-
pressor response. In particular, wavelet transforms and short time Fourier transforms
are often utilized in HRV studies, as they have different, but appropriate assumptions
for analyzing HRV. Also, it would likely be worthwhile to investigate a frequency mod-
ulation model of HRV in this experiment, as the relationship between the baseline
and stimulation recordings is highly analogous to frequency modulation.
4.7 Refining the Experimental Protocol
The experimental protocol could be improved to better assess spontaneous animal
stability. Based on the findings in this work, there are at least two main additions to
the protocol that could greatly assist in assessing cardiovascular stability:
1. Creating a live display of the animal’s ECG histogram, whereby a continuously
moving ten-minute interval of ECG histogram is visually monitored
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2. Creating a live display of the FFT of the BP profile, which could be used
to immediately assess respiration rate. This would be particularly useful in
determining if the animal is accepting the respirator.
4.8 Conclusion
Overall, it was found that the most meaningful frequency-based measurements of
HRV are focused on PNS activity, particularly with measurements focused on the
respiratory band. Based on the measurements in this work, there is strong potential
in three HRV measures utilizing the FFT and PSD method:
1. Integrating HF band absolute power in gaussian data (more ns needed)
2. Integrating respiratory peak power for α = 10% in gaussian data
3. Integrating respiratory peak power for α = 5% in gaussian data
In these measurements, it is crucial to restrict data sets appropriately based on
animal stability. Given the high levels of significance measured with respiratory peak
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